<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff6; src: url("6.ttf"); }
#f1 { font-family:ff6,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f2 { font-family:ff0,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff7; src: url("7.ttf"); }
#f3 { font-family:ff7,serif; font-weight:normal; font-style:normal; }
#f4 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f5 { font-family:ff4,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.ttf"); }
#f6 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="842" src="page22.png">
<div class="txt" style="position:absolute; left:437px; top:54px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">삼성바이오로직스(207940)</span></div>
<div class="txt" style="position:absolute; left:59px; top:106px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">[그림 23] 삼성바이오에피스 베네팔리 로열티 추이 및 전망</span></div>
<div class="txt" style="position:absolute; left:76px; top:121px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(십억원)</span></div>
<div class="txt" style="position:absolute; left:61px; top:130px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">140</span></div>
<div class="txt" style="position:absolute; left:61px; top:150px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">120</span></div>
<div class="txt" style="position:absolute; left:245px; top:147px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">114</span></div>
<div class="txt" style="position:absolute; left:271px; top:146px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">116</span></div>
<div class="txt" style="position:absolute; left:220px; top:164px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">98</span></div>
<div class="txt" style="position:absolute; left:61px; top:170px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">100</span></div>
<div class="txt" style="position:absolute; left:194px; top:182px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">80</span></div>
<div class="txt" style="position:absolute; left:65px; top:190px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">80</span></div>
<div class="txt" style="position:absolute; left:167px; top:198px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">64</span></div>
<div class="txt" style="position:absolute; left:65px; top:210px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">60</span></div>
<div class="txt" style="position:absolute; left:141px; top:216px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">46</span></div>
<div class="txt" style="position:absolute; left:65px; top:230px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">40</span></div>
<div class="txt" style="position:absolute; left:115px; top:234px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">28</span></div>
<div class="txt" style="position:absolute; left:65px; top:250px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">20</span></div>
<div class="txt" style="position:absolute; left:90px; top:256px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">6</span></div>
<div class="txt" style="position:absolute; left:68px; top:270px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">0</span></div>
<div class="txt" style="position:absolute; left:85px; top:277px;"><span id="f6" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2016 2017F 2018F 2019F 2020F 2021F 2022F 2023F</span></div>
<div class="txt" style="position:absolute; left:57px; top:292px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료: 삼성바이오에피스, 한국투자증권</span></div>
<div class="txt" style="position:absolute; left:300px; top:106px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">[그림 24] 셀트리온헬스케어, Amgen 영업이익률 추이</span></div>
<div class="txt" style="position:absolute; left:313px; top:121px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">(%)</span></div>
<div class="txt" style="position:absolute; left:302px; top:129px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">45</span></div>
<div class="txt" style="position:absolute; left:302px; top:145px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">40</span></div>
<div class="txt" style="position:absolute; left:428px; top:142px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">39.1</span></div>
<div class="txt" style="position:absolute; left:302px; top:161px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">35</span></div>
<div class="txt" style="position:absolute; left:302px; top:177px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">30</span></div>
<div class="txt" style="position:absolute; left:359px; top:174px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">30.9</span></div>
<div class="txt" style="position:absolute; left:302px; top:193px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">25</span></div>
<div class="txt" style="position:absolute; left:359px; top:200px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">22.7</span></div>
<div class="txt" style="position:absolute; left:302px; top:208px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">20</span></div>
<div class="txt" style="position:absolute; left:431px; top:181px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">27.8</span></div>
<div class="txt" style="position:absolute; left:302px; top:224px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">15</span></div>
<div class="txt" style="position:absolute; left:302px; top:240px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">10</span></div>
<div class="txt" style="position:absolute; left:396px; top:242px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">셀트리온헬스케어</span></div>
<div class="txt" style="position:absolute; left:305px; top:256px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">5</span></div>
<div class="txt" style="position:absolute; left:305px; top:272px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">0</span></div>
<div class="txt" style="position:absolute; left:344px; top:278px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">2014</span></div>
<div class="txt" style="position:absolute; left:298px; top:292px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료: 전자공시시스템, 한국투자증권</span></div>
<div class="txt" style="position:absolute; left:416px; top:278px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">2015</span></div>
<div class="txt" style="position:absolute; left:502px; top:137px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">42.6</span></div>
<div class="txt" style="position:absolute; left:502px; top:197px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">23.6</span></div>
<div class="txt" style="position:absolute; left:483px; top:242px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">Amgen</span></div>
<div class="txt" style="position:absolute; left:488px; top:278px;"><span id="f6" style="font-size:5px;vertical-align:baseline;color:rgba(0,0,0,1);">2016</span></div>
<div class="txt" style="position:absolute; left:56px; top:337px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">두 번째는 Remicade</span></div>
<div class="txt" style="position:absolute; left:56px; top:451px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">그 외 파이프라인들..</span></div>
<div class="txt" style="position:absolute; left:189px; top:320px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,159,197,1);">3) 계속되는 파이프라인 follow-up</span></div>
<div class="txt" style="position:absolute; left:189px; top:337px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오에피스는 Enbrel의 바이오시밀러 외에 류마티스, 건선, 관절염 치료제인 Remicade</span></div>
<div class="txt" style="position:absolute; left:189px; top:351px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">의 바이오시밀러 플릭사비(미국/국내명 렌플렉시스)를 셀트리온에 이어 두 번째로 유럽시</span></div>
<div class="txt" style="position:absolute; left:189px; top:366px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">장에 출시했다. Remicade의 특허가 2015년 2월 유럽에서 만료됨에 따라 바이오에피스도</span></div>
<div class="txt" style="position:absolute; left:189px; top:380px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">2016년 2월 유럽 EMA로부터 판매허가를 취득했다. 유럽시장에서의 마케팅 파트너는</span></div>
<div class="txt" style="position:absolute; left:189px; top:394px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">Merck이다. 이후 2017년 4월 셀트리온(2016년 11월)에 이어 미국에서도 FDA로부터 판</span></div>
<div class="txt" style="position:absolute; left:189px; top:408px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">매를 승인받으면서 Remicade 바이오시밀러의 매출기여는 2018년부터 점진적으로 확대될</span></div>
<div class="txt" style="position:absolute; left:189px; top:422px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">전망이다.</span></div>
<div class="txt" style="position:absolute; left:189px; top:451px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">내년부터는 2015년 5월 유럽에서 특허가 만료된 당뇨치료제 Lantus의 바이오시밀러 루</span></div>
<div class="txt" style="position:absolute; left:189px; top:465px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">수두나의 미국과 유럽 출시도 기대해볼 수 있다. 동사는 2017년 1월 유럽에서 루수두나에</span></div>
<div class="txt" style="position:absolute; left:189px; top:479px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">대한 판매승인을 득했으며 미국 내 특허도 2017년 6월 만료되기 때문이다.</span></div>
<div class="txt" style="position:absolute; left:189px; top:508px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">한편 Abbvie의 류마티스 관절염 치료제 Humira 역시 미국과 유럽 시장에서 2018년 특허</span></div>
<div class="txt" style="position:absolute; left:189px; top:522px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">가 만료될 예정이었으나 2022년과 2023년으로 특허기간을 연장한 바 있다. 바이오에피스</span></div>
<div class="txt" style="position:absolute; left:189px; top:536px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">는 Biogen과 함께 Abbvie를 상대로 특허무효 소송을 걸어 올 3월 승소한 바 있다. 올해</span></div>
<div class="txt" style="position:absolute; left:189px; top:550px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">6월에는 EMA CHMP(약물사용자문위원회)로부터 승인권고를 받음에 따라 2~3개월 뒤에</span></div>
<div class="txt" style="position:absolute; left:189px; top:564px;"><span id="f5" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">는 Humira의 바이오시밀러 임랄디의 유럽 시장 내 판매승인이 기대된다.</span></div>
<div class="txt" style="position:absolute; left:189px; top:590px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">&lt;표 10&gt; 2016년 바이오의약품 글로벌 매출 및 순위</span></div>
<div class="txt" style="position:absolute; left:213px; top:606px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">브랜드명 성분명</span></div>
<div class="txt" style="position:absolute; left:337px; top:606px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">매출액</span></div>
<div class="txt" style="position:absolute; left:189px; top:617px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">1</span></div>
<div class="txt" style="position:absolute; left:213px; top:617px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Humira Adalimumab</span></div>
<div class="txt" style="position:absolute; left:342px; top:617px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">16.4</span></div>
<div class="txt" style="position:absolute; left:189px; top:628px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2</span></div>
<div class="txt" style="position:absolute; left:213px; top:628px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Enbrel</span></div>
<div class="txt" style="position:absolute; left:253px; top:628px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Etandercept</span></div>
<div class="txt" style="position:absolute; left:346px; top:628px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">9.2</span></div>
<div class="txt" style="position:absolute; left:189px; top:640px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">3</span></div>
<div class="txt" style="position:absolute; left:213px; top:640px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Remicade Infliximab</span></div>
<div class="txt" style="position:absolute; left:346px; top:640px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">8.8</span></div>
<div class="txt" style="position:absolute; left:189px; top:651px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">4</span></div>
<div class="txt" style="position:absolute; left:213px; top:651px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Rituxan Rituximab</span></div>
<div class="txt" style="position:absolute; left:346px; top:651px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">7.1</span></div>
<div class="txt" style="position:absolute; left:189px; top:662px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">5</span></div>
<div class="txt" style="position:absolute; left:213px; top:662px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Avastin Bevacizumab</span></div>
<div class="txt" style="position:absolute; left:346px; top:662px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6.6</span></div>
<div class="txt" style="position:absolute; left:189px; top:674px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6</span></div>
<div class="txt" style="position:absolute; left:213px; top:674px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Herceptin Trastuzumab</span></div>
<div class="txt" style="position:absolute; left:346px; top:674px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6.6</span></div>
<div class="txt" style="position:absolute; left:189px; top:685px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">7</span></div>
<div class="txt" style="position:absolute; left:213px; top:685px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Lantus</span></div>
<div class="txt" style="position:absolute; left:253px; top:685px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Insulin glargine</span></div>
<div class="txt" style="position:absolute; left:346px; top:685px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">6.1</span></div>
<div class="txt" style="position:absolute; left:189px; top:700px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">8</span></div>
<div class="txt" style="position:absolute; left:213px; top:700px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Prenvar13</span></div>
<div class="txt" style="position:absolute; left:253px; top:695px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Pneumococcal 13-valent</span></div>
<div class="txt" style="position:absolute; left:253px; top:704px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Conjugate vaccine</span></div>
<div class="txt" style="position:absolute; left:346px; top:700px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">5.7</span></div>
<div class="txt" style="position:absolute; left:189px; top:715px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">9</span></div>
<div class="txt" style="position:absolute; left:213px; top:715px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Neulasta Pegfilgrastim</span></div>
<div class="txt" style="position:absolute; left:346px; top:715px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">4.6</span></div>
<div class="txt" style="position:absolute; left:189px; top:726px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">10 NovoRapid Insulin aspart</span></div>
<div class="txt" style="position:absolute; left:346px; top:726px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">2.8</span></div>
<div class="txt" style="position:absolute; left:189px; top:740px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료: Frost &amp; Sullivan, 한국투자증권</span></div>
<div class="txt" style="position:absolute; left:384px; top:606px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">판매사</span></div>
<div class="txt" style="position:absolute; left:384px; top:617px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Abbvie</span></div>
<div class="txt" style="position:absolute; left:384px; top:628px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Amgen</span></div>
<div class="txt" style="position:absolute; left:384px; top:640px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Jansen</span></div>
<div class="txt" style="position:absolute; left:384px; top:651px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Roche</span></div>
<div class="txt" style="position:absolute; left:384px; top:662px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Roche</span></div>
<div class="txt" style="position:absolute; left:384px; top:674px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Roche</span></div>
<div class="txt" style="position:absolute; left:384px; top:685px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Sanofi</span></div>
<div class="txt" style="position:absolute; left:384px; top:700px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Pfizer</span></div>
<div class="txt" style="position:absolute; left:384px; top:715px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Amgen</span></div>
<div class="txt" style="position:absolute; left:384px; top:726px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Novo Nordisk</span></div>
<div class="txt" style="position:absolute; left:492px; top:592px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(단위: 십억달러)</span></div>
<div class="txt" style="position:absolute; left:439px; top:606px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">주요 적응증</span></div>
<div class="txt" style="position:absolute; left:439px; top:617px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">류마티스 관절염</span></div>
<div class="txt" style="position:absolute; left:439px; top:628px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">류마티스 관절염</span></div>
<div class="txt" style="position:absolute; left:439px; top:640px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">류마티스 관절염</span></div>
<div class="txt" style="position:absolute; left:439px; top:651px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">비호 지킨 림프종</span></div>
<div class="txt" style="position:absolute; left:439px; top:662px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">암 (결장, 폐, 신장 등)</span></div>
<div class="txt" style="position:absolute; left:439px; top:674px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">유방암</span></div>
<div class="txt" style="position:absolute; left:439px; top:685px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">당뇨병</span></div>
<div class="txt" style="position:absolute; left:439px; top:700px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">폐렴 구균 성 폐렴</span></div>
<div class="txt" style="position:absolute; left:439px; top:715px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">호중구 감소증</span></div>
<div class="txt" style="position:absolute; left:439px; top:726px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">당뇨병</span></div>
<div class="txt" style="position:absolute; left:522px; top:801px;"><span id="f4" style="font-size:10px;vertical-align:baseline;color:rgba(127,127,127,1);">21</span></div>
</body>
</html>
